Perlara PBC
Industry
- Biotechnology
- Drug Discovery Technologies
- Genomics-Proteomics
- Molecular Diversity
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Perlara PBC
The US Food and Drug Administration’s announcement of Vinayak “Vinay” Prasad as the new director of the Center for Biologics Evaluation and Research may signal a major philosophical shift in the data
Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Deerfiel
Biopharma has been talking for years about the necessity for a new business model, one that reconciles the aim of expanding patient access to the latest medicine at a price point conducive to supporti
Biopharma start-ups brought in nearly two-and-a-half times as much funding in the fourth quarter as in the third quarter. Novartis AG was one of five big pharma companies to pen an alliance with a